Cargando…
Validation of living with chronic illness scale in a type 2 diabetes mellitus population
BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHOD...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972215/ https://www.ncbi.nlm.nih.gov/pubmed/33731142 http://dx.doi.org/10.1186/s12955-021-01715-x |
_version_ | 1783666681060524032 |
---|---|
author | Caro-Bautista, Jorge Rodríguez-Blázquez, Carmen Perez-Manchon, David Timonet-Andreu, Eva Carvajal-Carrascal, Gloria Fuentes-Ramírez, Alejandra Corchon, Silvia Aranda-Gallardo, Marta Ambrosio, Leire |
author_facet | Caro-Bautista, Jorge Rodríguez-Blázquez, Carmen Perez-Manchon, David Timonet-Andreu, Eva Carvajal-Carrascal, Gloria Fuentes-Ramírez, Alejandra Corchon, Silvia Aranda-Gallardo, Marta Ambrosio, Leire |
author_sort | Caro-Bautista, Jorge |
collection | PubMed |
description | BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHODS: In this observational, international, cross-sectional study, 582 persons with T2DM were recruited in primary care and outpatient hospital consultations, in Spain and Colombia, during the period from May 2018 to June 2019. The properties analysed were feasibility/acceptability, internal consistency, reliability, precision and (structural) content-construct validity including confirmatory factor analysis. The COSMIN checklist was used to assess the methodological/psychometric quality of the instrument. RESULTS: The scale had an adequate internal consistency and test retest reliability (Cronbach’s alpha = 0.90; intraclass correlation coefficient = 0.96, respectively). In addition, the instrument is precise (standard error of measurement = 3.34, with values < ½SD = 8.52) and correlates positively with social support (DUFSS) (r(s) = 0.56), quality of life (WHOQOL-BREF) (r(s) = 0.51–0.30) and ssatisfaction with life (SLS-6) (r(s) = 0.50–0.38). The original 26-items version of the scale did not support totally the confirmatory factor analysis. The COSMIN checklist is favourable for all the properties analysed, although weaknesses are detected for structural validity. CONCLUSIONS: The LW-CI-T2DM is a valid, reliable and accurate instrument for use in clinical practice to determine how a person’s life is affected by the presence of diabetes. This instrument correlates well with the associated constructs of social support, quality of life and satisfaction. Additional research is needed to determine how well the questionnaire structure performs when robust factor analysis methods are applied. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01715-x. |
format | Online Article Text |
id | pubmed-7972215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79722152021-03-19 Validation of living with chronic illness scale in a type 2 diabetes mellitus population Caro-Bautista, Jorge Rodríguez-Blázquez, Carmen Perez-Manchon, David Timonet-Andreu, Eva Carvajal-Carrascal, Gloria Fuentes-Ramírez, Alejandra Corchon, Silvia Aranda-Gallardo, Marta Ambrosio, Leire Health Qual Life Outcomes Research BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHODS: In this observational, international, cross-sectional study, 582 persons with T2DM were recruited in primary care and outpatient hospital consultations, in Spain and Colombia, during the period from May 2018 to June 2019. The properties analysed were feasibility/acceptability, internal consistency, reliability, precision and (structural) content-construct validity including confirmatory factor analysis. The COSMIN checklist was used to assess the methodological/psychometric quality of the instrument. RESULTS: The scale had an adequate internal consistency and test retest reliability (Cronbach’s alpha = 0.90; intraclass correlation coefficient = 0.96, respectively). In addition, the instrument is precise (standard error of measurement = 3.34, with values < ½SD = 8.52) and correlates positively with social support (DUFSS) (r(s) = 0.56), quality of life (WHOQOL-BREF) (r(s) = 0.51–0.30) and ssatisfaction with life (SLS-6) (r(s) = 0.50–0.38). The original 26-items version of the scale did not support totally the confirmatory factor analysis. The COSMIN checklist is favourable for all the properties analysed, although weaknesses are detected for structural validity. CONCLUSIONS: The LW-CI-T2DM is a valid, reliable and accurate instrument for use in clinical practice to determine how a person’s life is affected by the presence of diabetes. This instrument correlates well with the associated constructs of social support, quality of life and satisfaction. Additional research is needed to determine how well the questionnaire structure performs when robust factor analysis methods are applied. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01715-x. BioMed Central 2021-03-17 /pmc/articles/PMC7972215/ /pubmed/33731142 http://dx.doi.org/10.1186/s12955-021-01715-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Caro-Bautista, Jorge Rodríguez-Blázquez, Carmen Perez-Manchon, David Timonet-Andreu, Eva Carvajal-Carrascal, Gloria Fuentes-Ramírez, Alejandra Corchon, Silvia Aranda-Gallardo, Marta Ambrosio, Leire Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title | Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title_full | Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title_fullStr | Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title_full_unstemmed | Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title_short | Validation of living with chronic illness scale in a type 2 diabetes mellitus population |
title_sort | validation of living with chronic illness scale in a type 2 diabetes mellitus population |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972215/ https://www.ncbi.nlm.nih.gov/pubmed/33731142 http://dx.doi.org/10.1186/s12955-021-01715-x |
work_keys_str_mv | AT carobautistajorge validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT rodriguezblazquezcarmen validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT perezmanchondavid validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT timonetandreueva validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT carvajalcarrascalgloria validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT fuentesramirezalejandra validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT corchonsilvia validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT arandagallardomarta validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation AT ambrosioleire validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation |